Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2018 Volume 16 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2018 Volume 16 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells

  • Authors:
    • Li Huang
    • Chuankong Sun
    • Ruobing Peng
    • Zhiming Liu
  • View Affiliations / Copyright

    Affiliations: Department of Stomatology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China
    Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 4367-4372
    |
    Published online on: September 25, 2018
       https://doi.org/10.3892/etm.2018.6792
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to explore the mechanism of agonists in regulating transcriptional level of polymeric immunoglobulin receptor (pIgR) in salivary gland epithelial cells, thus revealing the defense effect of salivary immune on bacteria in the oral cavity. Sixty patients with oral bacterial infection and 70 patients suffering from oral diseases without bacterial infection were selected randomly from patients in Renmin Hospital of Wuhan University from April 2015 to April 2017. Ribonucleic acid (RNA) was extracted from salivary gland epithelial cells of all patients. Fluorescent quantitative polymerase chain reaction (FQ-PCR) and western blotting methods were adopted to detect and compare the transcriptional level of pIgR. The salivary gland epithelial cells of the 60 patients with oral bacterial infection were isolated and extracted, and they were divided into two groups (observation group and control group) randomly. Agonists were added to the observation group for acting for 24 h. FQ-PCR and immunofluorescence (IF) were adopted to detect and compare the transcriptional level of pIgR after acting with agonists. The toxicity of agonists on the cells was detected with Cell Counting kit-8 (CCK-8). The isolated salivary gland epithelial cells conformed to the morphology of epithelial cells, and adhered to the wall for growing. The transcriptional level of pIgR in the bacterial infection group was lower than that in the non‑bacterial infection group (p<0.05). The transcriptional level of pIgR in the observation group was higher than that in the control group (p<0.05) after acting with agonists. Agonists can promote the rise of transcriptional level of pIgR in salivary gland epithelial cells, and the increase in pIgR is closely related to the cure of oral bacterial infection. Therefore, agonists can improve the oral immune function by regulating the transcription of pIgR.

Introduction

Oral cavity is a naturally open system, and the immune molecules in the saliva play important roles in immune defense and protection (1). The regulation of the flora in the mouth to keep them balanced, and the prevention of dental caries decide the oral health. The integrity of the mucosa should be maintained to avoid direct effects of harmful substances on the mucosa. The substances in the oral cavity should be cleared and excreted to keep the mouth relatively clean and sanitary, e.t.c. (2,3). As an important member of mucosal immune, polymeric immunoglobulin receptor (pIgR) is a member of immunoglobulin superfamily, and the only transporting receptor of polymeric immunoglobulin A (pIgA) and polymeric immunoglobulin M (pIgM). It is synthesized from mucosa epithelial cells and exocrine gland epithelial cells, and can clear antigen and harmful substances in the mucosa, which plays an important role in the first line of defense in the immune system (4,5). Therefore, the study on the active ingredient (pIgR) in the saliva is of great significance and prospect. This study analyzed the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells, thus revealing the defense effect of salivary immune on bacteria in the oral cavity.

Materials and methods

General data

A total of 60 patients with oral bacterial infection and 70 patients suffering from oral diseases without bacterial infection were selected randomly from patients that were treated in Renmin Hospital of Wuhan University (Wuhan, China) from April 2015 to April 2017. Inclusion criteria: patients whose sublingual gland tissues needed to be removed for the treatment of their diseases. Exclusion criteria: patients with severe diseases in cardiovascular or digestive systems, mental diseases, infectious diseases, e.t.c., that had an impact on the test results. Patients in the group with bacterial infection of other organs were aged 19–51 years old with an average of 36.12±10.32 years old, including 38 males and 22 females, among which 22 patients were mainly infected with oral streptococci, 10 with Streptococcus salivarius and 28 with Streptococcus sanguis. Patients in the group without bacterial infection were aged 18–52 years old with an average of 35.78±11.42 years old, including 44 males and 26 females. The data (such as age and sex) of the two groups of patients had no statistical differences (p>0.05), and they were comparable. The study was approved by the Ethics Committee of Renmin Hospital of Wuhan University and written informed consents were signed by the patients.

Reagents

DMEM/F12 culture medium (HyClone; GE Healthcare Life Sciences, Logan, UT, USA); fetal bovine serum (FBS) (Lanzhou Bailing, Lanzhou, China); TRIzol (Life Technologies; Thermo Fisher Scientific, Inc., Waltham, MA, USA); reverse transcription kit (Takara Biotechnology Co., Ltd., Dalian, China); SYBR® Premix Ex Taq™ II kit (Takara Biotechnology Co., Ltd.); rabbit anti-human pIgR primary antibody and goat anti-rabbit secondary antibody (Abcam, Cambridge, MA, USA); cellulose acetate membrane (EMD Millipore, Burlington, MA, USA); developing liquid and fixing liquid (Beijing Transgen Biotech Co., Ltd., Beijing, China), internal reference glyceraldehyde-3-phosphate dehydrogenase (GAPDH), primer of pIgR (Shanghai Sangon, Shanghai, China), and Cell Counting kit-8 (CCK-8) (Dojindo Molecular Technologies, Inc., Shanghai, China).

Methods
Isolation of salivary gland epithelial cells (6)

The removed salivary glands were washed with sterile phosphate-buffered saline (PBS) for 2–3 times. They were cut into small pieces (1–2 mm3) with a scissor, and incubated in the culture plates. Dulbecco's modified Eagle's medium/F12 (DMEM/F12) [containing penicillin, streptomycin, epidermal growth factor (EGF), insulin and hydrocortisone] with 3% FBS was added. Then they were placed in the incubator containing 5% carbon dioxide (CO2) for culturing. Three days later, the culture solution was replaced. Thereafter, the culture solution was replaced once every 3 days. The cells were passaged when 70–80% cells grew and fused.

Fluorescent quantitative polymerase chain reaction (FQ-PCR) analysis on transcriptional level of pIgR

Ribonucleic acid (RNA) of the cell specimen was extracted, and the concentration was measured. RNA (1 µg) was taken to carry out reverse transcription reaction with reverse transcription enzyme-reagent kits, thus obtaining complementary DNA (cDNA). The concentration of cDNA was adjusted, and Bio-Rad CFX 96 PCR (Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used to measure the relative expression volume of messenger RNA (mRNA) of different groups according to the illustration of SYBR® Premix Ex Taq™ II kits. The sequences of the corresponding primers are shown in Table I, and the setting of PCR program is demonstrated in Table II.

Table I.

Primer sequences of GAPDH, alkaline phosphatase (ALP) and osteocalcin (OCN).

Table I.

Primer sequences of GAPDH, alkaline phosphatase (ALP) and osteocalcin (OCN).

Name of the geneSequence of primers
β-actinForward: 5′-GCTTGGAATGAGACTGCTGA-3′
Reverse: 5′-CTGGCCATATCCACCAGAGT-3′
pIgRForward: 5′-TCAGGTGCTTTGCTAGATG-3′
Reverse: 5′-TTTGGGTGTAAGAATGGTAA-3′

Table II.

Program of PCR.

Table II.

Program of PCR.

StepTemperatureTimeCirculation
194°C15 min  1
294°C10 sec40
50°C30 sec
72°C15 sec
Read
372°C10 min  1
Detection of protein expression of pIgR with western blotting (7,8)

Salivary gland cells were digested with pancreatin and transferred to the radio-immunoprecipitation assay (RIPA) protein lysate. The resulted solution was lysed for 30 min on ice, during which vortex mixing was conducted for 3 times. Then it was centrifuged for 10 min at 4°C in a rate of 12,000 × g. The supernatant was filled in a 1.5 ml Eppendorf (EP) tube. Part of the supernate was taken to detect the concentration of protein by bicinchoninic acid (BCA) method. Then part of the supernatant was taken to ensure that the content of protein in each specimen waiting for test was 100 µg. Reduced loading buffer (5X) was added, and boiled with boiled water for 10 min. The afore-mentioned sample solution was added slowly to the prepared gel wells for sample loading with microsyringes. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE; 15%) was conducted under the voltage of 80 V. Wet transfer was conducted for 0.5 h under the voltage of 40 V after the end of electrophoresis. The target protein in the gel was transferred to nitrocellulose (NC) membrane. Then the membrane was rinsed with eluent for at least 3 times (10 min/time), and rabbit anti-human pIgR polyclonal antibody (1:600; cat no. ab96196; Abcam) was added to the membrane. The membrane was blocked overnight with skimmed milk powder at 4°C. The primary antibody was incubated for 2 h, and the goat anti-rabbit secondary polyclonal antibody (1:1,000; cat no. ab6721; Abcam) was incubated for 1 h at room temperature. Fluorogenic substrate was added, and pressed in the dark room for the formation of images.

Detection of protein expression in pIgR with immunofluorescence (9)

The slides filled with cells in the culture plates were rinsed with PBS for 3 times (3 min/time). The slides were fixed with 4% paraformaldehyde for 15 min, and rinsed with PBS for 3 times (3 min/time). Triton X-100 (0.5%) (prepared with PBS) was added, and allowed to stand at room temperature for 20 min. The glass slides were rinsed with PBS for 3 times (3 min/time); then absorbent paper was used to absorb PBS. Normal goat serum was dripped on the glass slides, and they were blocked at room temperature for 30 min. A sufficient amount of diluted primary antibody was dripped to each slide. Then the slides were incubated in the wet box overnight at 4°C. Fluorescent secondary antibody was added. The slides were rinsed with PBS containing Tween-20 (PBST) for 3 times (30 min/time), and incubated in the wet box at room temperature for 1 h. They were rinsed with PBST, and cut into slices for 3 times (3 min/time). Diamidino-phenyl-indole (DAPI) was added, and the slides were incubated away from light for 5 min. Staining was conducted for the specimen, and the slides were rinsed with PBST to remove excessive DAPI. The slides were sealed with slide-sealing solution containing anti-fluorescence quenching agent; then the slides were placed under the fluorescence microscope to observe and collect the images.

Detection of survival rate of cells with CCK-8

Cell suspension (100 µl) was prepared in 96-well plates. All the blank group, observation group and control group had 3 repeated wells. The culture plates were cultured in the incubator until the density of the cells reached 50%. Agonist solution (10 µl) was added to the observation group, and the equivalent volume of culture medium was added to the control group for incubation. Twenty-four hours later, 10 µl of CCK-8 solution was added to each well, and they were placed in the incubator for 2 h. The optical density at 450 nm was detected with microplate reader. Survival rate of cells = (OD in the observation group - OD in the blank group) / (OD in the control group - OD in the blank group).

Statistical methods

Statistical treatment was carried out with Statistical Product and Service Solutions (SPSS, Inc., Chicago, IL, USA) 17.0 software, and the test data were expressed as (mean ± SD). t-test was used for comparison. P<0.05 suggested that the comparison had a statistical difference.

Results

Isolation of salivary gland epithelial cells

The tissue blocks of salivary gland epithelial cells adhered to the wall for growing. They lined up closely and showed a typical shape of ‘paving stones’. It could be seen that small round and polygonal cells inlaid each other (Fig. 1).

Figure 1.

Salivary gland epithelial cells that were cultured in vitro by adhering to the wall.

Comparison of transcriptional level of pIgR in the infection group with that in the non-infection group before and after treatment

Total RNA of salivary gland epithelial cells with the purity (A260/A280) of 2.02 was extracted (Fig. 2). The results of FQ-PRC and western blotting methods showed that the transcriptional level of pIgR in the bacterial infection group was lower than that in the non-infection group before treatment (p<0.05), while the transcriptional level of pIgR in the bacterial infection group was increased after treatment, and the difference with that in the non-infection group showed no statistical significance (p>0.05) (Figs. 3 and 4).

Figure 2.

Agarose gel electrophoresis of RNA.

Figure 3.

Results of FQ-PCR of the two groups (A) before and (B) after treatment. Relative expression level of pIgR in the bacterial infection group is lower than that in the non-infection group before treatment (*p<0.05), while the relative expression level of pIgR in the bacterial infection group is increased after treatment, and the difference with that in the non-infection group has no statistical significance (p>0.05).

Figure 4.

Protein expression before and after treatment. Relative expression level of pIgR in the bacterial infection group is lower than that in the non-infection group before treatment (*p<0.05), while the relative expression level of pIgR in the bacterial infection group is increased after treatment, and the comparison with that in the non-infection group has no statistical significance (p>0.05). (A) Western blotting results of the two groups before and after treatment. (B) Analysis results of gray level of protein expression in the two groups before and after treatment.

Impacts of agonists on transcription of pIgR in salivary gland epithelial cells

FQ-PCR results showed that the transcriptional level of pIgR in the observation group was higher than that in the control group (p<0.05) after acting with agonists (Fig. 5). The immunofluorescence results indicated that the protein expressed by transcription in the observation group was higher than that in the control group (Fig. 6).

Figure 5.

FQ-PCR results show that the transcriptional level of pIgR in the observation group is higher than that in the control group (*p<0.05).

Figure 6.

The immunofluorescence results indicate that the protein expressed by transcription in the observation group is higher than that in the control group. (A) Immunofluorescence result of the control group. (B) Immunofluorescence result of the observation group.

Detection of toxicity of agonists on the cells with CCK-8

The average OD of blank wells was 0.212, and that in the control group and the observation group was 0.4114 and 0.402, respectively. It was calculated that the survival rate of cells in the observation group was 95.9%, while that in the control group was 100%. The difference had no statistical significance (p>0.05).

Discussion

There is a large number of microbial communities in the oral cavity, and in a sense, the health of the oral cavity is a reflection of the ecological balance of the bacteria. Once the balance is broken, the beneficial bacteria will be reduced, which will result in all kinds of oral inflammation and diseases (10,11). Oral streptococcus that often lives in the oral cavity plays an important role in the oral micro-ecological system, among which Streptococcus mutans are the main pathogenic bacteria of caries, Streptococcus sanguis is the pioneer in dental plaque, and Streptococcus buccalis and Streptococcus salivarius are the early colonized bacteria of oral mucosa (12). Colonization and dissemination of oral microorganisms are regulated and defended by the salivary immune system (13). Saliva is an important substance in oral immunity, and it contains lysozyme. There are lymphocytes and plasmacytes in the mesenchyme of salivary glands. IgA secreted by plasmacytes binds to the protein secretory components secreted by glandular cells, thus forming secreted IgA, which is released into the oral cavity with the saliva, and has an immunogenic effect (14). In recent years, the discussion on the effects of Streptococcus salivarius and Streptococcus mutans from the aspect of immunity has been a hotspot of research. A study of Carrasco-Yepez et al (15) found that the effects of Streptococcus salivarius and Streptococcus mutans are not specific. They are a manifestation of broad-spectrum non-specific effects. Kortum et al (16) held the opinion that alkaline phosphatase, lactate dehydrogenase and other relevant components in saliva immunity are highly correlated with the incidence of dental caries.

pIgR mediates the transcription of polymeric immunoglobulin in the epithelial cells, and participates in the formation of secretory immunoglobulin A (S-IgA) (17). pIgR has high affinity with dimer IgA (dIgA) with J chain near the external side of the base of the lamina propria, and forms a complex of ligand and receptor. Then the complex is actively transported to the apical end of the cell from the external side of the base through intracellular transport. The extracellular segment of pIgR binds covalently to dIgA at the apical end of the cell, and cleaves between transmembrane region and extracellular segment, thus secreting S-IgA. When viruses or foreign antigens penetrate the mucosal surface, and enter the lamina propria, pIgR also binds to immune complexes formed by IgA and antigen (Ag) to expel pathogens such as viruses and bacteria out of the body through transcytosis (18). A study conducted by DeSantis et al (19) showed that the impacts of pIgR on the structure, expression distribution, function and expression regulation are significantly associated with fish mucosal immunity. Qin et al (20) believed that polyimmunoglobulin receptors and secretion components are involved in multiple molecular mechanisms, and they play a very important role in mucosal immunity. The results of this study also found that the transcriptional expression of pIgR in salivary gland epithelial cells had a great relationship with disease-treating streptococcus in the oral cavity. The transcriptional level of pIgR in the bacterial infection group was lower than that in the non-infection group before treatment, while the transcriptional level of pIgR in the bacterial infection group was increased after treatment, and the level was equivalent to that in the non-infection group, which showed that oral bacterial infection can reduce the content of pIgR in oral cavity, which in turn leads to the decrease of oral salivary immunity. Agonist is a substance that enhances the transcriptional level of pIgR. This study also proved that transcriptional level of pIgR in the observation group was higher than that in the control group after acting with agonists (p<0.05), which suggested that promoters can affect the oral salivary immune function by improving the transcriptional level of pIgR, thus preventing and treating pathogens such as bacteria and virus in the mouth. Moreover, the use of agonists has no influence on normal proliferation of salivary gland epithelial cells, and it has relatively high safety.

In conclusion, agonists can promote the rise of the transcriptional level of pIgR in salivary gland epithelial cells, and the increase in pIgR is closely related to the cure of oral bacterial infection. Therefore, agonists can improve the oral immune function by regulating the transcription of pIgR.

Acknowledgements

Not applicable.

Funding

This study was sponsored by the National Natural Science Fund (81600860).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

LH and CS assisted with PCR and western blotting. RP and ZL were responsible for immunofluorescence. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The present study was approved by the Ethics Committee of Renmin Hospital of Wuhan University (Wuhan, China) and written informed consents were signed by the patients.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Rombout JH, Yang G and Kiron V: Adaptive immune responses at mucosal surfaces of teleost fish. Fish Shellfish Immunol. 40:634–643. 2014. View Article : Google Scholar : PubMed/NCBI

2 

López MC: Chronic alcohol consumption regulates the expression of poly immunoglobulin receptor (pIgR) and secretory IgA in the gut. Toxicol Appl Pharmacol. 333:84–91. 2017. View Article : Google Scholar : PubMed/NCBI

3 

Ward-Caviness CK, Neas LM, Blach C, Haynes CS, LaRocque-Abramson K, Grass E, Dowdy ZE, Devlin RB, Diaz-Sanchez D, Cascio WE, et al: A genome-wide trans-ethnic interaction study links the PIGR-FCAMR locus to coronary atherosclerosis via interactions between genetic variants and residential exposure to traffic. PLoS One. 12:e01738802017. View Article : Google Scholar : PubMed/NCBI

4 

Li D, Wang FJ, Yu L, Yao WR, Cui YF and Yang GB: Expression of pIgR in the tracheal mucosa of SHIV/SIV-infected rhesus macaques. Zool Res. 38:44–48. 2017.PubMed/NCBI

5 

Yue X, Ai J, Xu Y, Chen Y, Huang M, Yang X, Hu B, Zhang H, He C, Yang X, et al: Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma. Hepatology. 65:1948–1962. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Yang S, Liu S, Qu B, Dong Y and Zhang S: Identification of sea bass pIgR shows its interaction with vitellogenin inducing antibody-like activities in HEK 293T cells. Fish Shellfish Immunol. 63:394–404. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Armitage CW, O'Meara CP and Beagley KW: Chlamydial infection enhances expression of the polymeric immunoglobulin receptor (pIgR) and transcytosis of IgA. Am J Reprod Immunol. 77:e126112017. View Article : Google Scholar

8 

Qi X, Li X and Sun X: Reduced expression of polymeric immunoglobulin receptor (pIgR) in nasopharyngeal carcinoma and its correlation with prognosis. Tumour Biol. 37:11099–11104. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Zhang F, Liu D, Wang L, Li T, Chang Q, An L and Yang G: Characterization of IgM-binding protein: A pIgR-like molecule expressed by intestinal epithelial cells in the common carp (Cyprinus carpio L.). Vet Immunol Immunopathol. 167:30–35. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Yamamoto Y, To M, Hayashi T, Shimizu T, Kamata Y, Saruta J, Takahashi T and Tsukinoki K: Intake of indigestible carbohydrates influences IgA response and polymeric Ig receptor expression in the rat submandibular gland. Br J Nutr. 113:1895–1902. 2015. View Article : Google Scholar : PubMed/NCBI

11 

Simpfendorfer KR, Strugnell RA, Brodnicki TC and Wijburg OL: Increased autoimmune diabetes in pIgR-deficient NOD mice is due to a ‘Hitchhiking’ interval that refines the genetic effect of Idd5.4. PLoS One. 10:e01219792015. View Article : Google Scholar : PubMed/NCBI

12 

Sankineni S, Cho Y, Hosseinian N and Kolliputi N: Does pIgR down-regulation in COPD cause reprogramming of bronchial epithelium? Lung. 193:1–2. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Niu H, Wang K and Wang Y: Polymeric immunoglobulin receptor expression is predictive of poor prognosis in glioma patients. Int J Clin Exp Med. 7:2185–2190. 2014.PubMed/NCBI

14 

Iovino F, Molema G and Bijlsma JJ: Streptococcus pneumoniae Interacts with pIgR expressed by the brain microvascular endothelium but does not co-localize with PAF receptor. PLoS One. 9:e979142014. View Article : Google Scholar : PubMed/NCBI

15 

Carrasco-Yepez M, Campos-Rodriguez R, Lopez-Reyes I, Bonilla-Lemus P, Rodriguez-Cortes AY, de Oca Contis-Montes A, Jarillo-Luna A, Miliar-Garcia A and Rojas-Hernandez S: Intranasal coadministration of Cholera toxin with amoeba lysates modulates the secretion of IgA and IgG antibodies, production of cytokines and expression of pIgR in the nasal cavity of mice in the model of Naegleria fowleri meningoencephalitis. Exp Parasitol. 145 Suppl:S84–S92. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Kortum AN, Rodriguez-Nunez I, Yang J, Shim J, Runft D, O'Driscoll ML, Haire RN, Cannon JP, Turner PM, Litman RT, et al: Differential expression and ligand binding indicate alternative functions for zebrafish polymeric immunoglobulin receptor (pIgR) and a family of pIgR-like (PIGRL) proteins. Immunogenetics. 66:267–279. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Trevisi P, Gandolfi G, Priori D, Messori S, Colombo M, Mazzoni M, Lallès JP and Bosi P: Age-related expression of the polymeric immunoglobulin receptor (pIgR) in the gastric mucosa of young pigs. PLoS One. 8:e814732013. View Article : Google Scholar : PubMed/NCBI

18 

Xu T, Xie W, Ma Y, Zhou S, Zhang L, Chen J, Cai M, Sun R, Zhang P, Yu S, et al: Leptin/OB-R pathway promotes IL-4 secretion from B lymphocytes and induces salivary gland epithelial cell apoptosis in Sjögren's syndrome. Oncotarget. 8:63417–63429. 2017.PubMed/NCBI

19 

DeSantis KA, Stabell AR, Spitzer DC, O'Keefe KJ, Nelson DA and Larsen M: RARα and RARγ reciprocally control K5+ progenitor cell expansion in developing salivary glands. Organogenesis. 13:125–140. 2017. View Article : Google Scholar : PubMed/NCBI

20 

Qin R, Steel A and Fazel N: Oral mucosa biology and salivary biomarkers. Clin Dermatol. 35:477–483. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Huang L, Sun C, Peng R and Liu Z: A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells. Exp Ther Med 16: 4367-4372, 2018.
APA
Huang, L., Sun, C., Peng, R., & Liu, Z. (2018). A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells. Experimental and Therapeutic Medicine, 16, 4367-4372. https://doi.org/10.3892/etm.2018.6792
MLA
Huang, L., Sun, C., Peng, R., Liu, Z."A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells". Experimental and Therapeutic Medicine 16.6 (2018): 4367-4372.
Chicago
Huang, L., Sun, C., Peng, R., Liu, Z."A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells". Experimental and Therapeutic Medicine 16, no. 6 (2018): 4367-4372. https://doi.org/10.3892/etm.2018.6792
Copy and paste a formatted citation
x
Spandidos Publications style
Huang L, Sun C, Peng R and Liu Z: A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells. Exp Ther Med 16: 4367-4372, 2018.
APA
Huang, L., Sun, C., Peng, R., & Liu, Z. (2018). A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells. Experimental and Therapeutic Medicine, 16, 4367-4372. https://doi.org/10.3892/etm.2018.6792
MLA
Huang, L., Sun, C., Peng, R., Liu, Z."A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells". Experimental and Therapeutic Medicine 16.6 (2018): 4367-4372.
Chicago
Huang, L., Sun, C., Peng, R., Liu, Z."A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells". Experimental and Therapeutic Medicine 16, no. 6 (2018): 4367-4372. https://doi.org/10.3892/etm.2018.6792
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team